Department of Paediatrics, Faculty of Medicine, Kandahar University, Kandahar 3809, Afghanistan.
Department of Surgery, Faculty of Medicine, Kandahar University, Kandahar 3809, Afghanistan.
Trans R Soc Trop Med Hyg. 2022 Dec 2;116(12):1181-1190. doi: 10.1093/trstmh/trac066.
Tuberculous meningitis (TBM) is the most severe form of TB. We prospectively documented the treatment outcomes and the risk factors for death in children with TBM from Kandahar, Afghanistan.
This prospective observational cohort study was conducted from February 2017 to January 2020 in hospitalised TBM children. All the patients were prospectively followed up for 12 mo. Data were analysed by using descriptive statistics, χ2 and multivariate logistic regression.
A total of 818 TBM hospitalised patients with median age 4.8 (0.8-14.5) y were recruited. Females accounted for 60.9% (498/818). Upon admission 53.9% (n=441) and 15.2% (n=124) had TBM stages II and III, respectively, and 23.2% (n=190) had focal neurological signs. The case fatality rate was 20.2% (160/794) and 30.6% (243/794) survived with neurological sequelae. Independent risk factors for death were being unvaccinated for BCG (adjusted OR [AOR] 3.8, 95% CI 1.8 to 8.1), not receiving dexamethasone (AOR 2.5, 95% CI 1.5 to 4.2), being male (AOR 2.3, 95% CI 1.5 to 3.6), history of recent weight loss (AOR 2.2, 95% CI 1.3 to 3.9) and having stage III TBM (AOR 2.0, 95% CI 1.2 to 3.3).
TBM continues to cause high morbidity and mortality in Afghan children. Strategies to reduce mortality should emphasise early diagnosis and treatment, routine use of dexamethasone and increased BCG vaccination.
结核性脑膜炎(TBM)是最严重的结核病形式。我们前瞻性地记录了来自阿富汗坎大哈的 TBM 患儿的治疗结果和死亡风险因素。
本前瞻性观察队列研究于 2017 年 2 月至 2020 年 1 月在住院 TBM 患儿中进行。所有患者均前瞻性随访 12 个月。采用描述性统计、χ2 和多变量逻辑回归进行数据分析。
共纳入 818 例 TBM 住院患儿,中位年龄为 4.8(0.8-14.5)岁,女性占 60.9%(498/818)。入院时,53.9%(n=441)和 15.2%(n=124)分别为 TBM Ⅱ期和Ⅲ期,23.2%(n=190)有局灶性神经体征。病死率为 20.2%(160/794),20.2%(243/794)存活且伴有神经后遗症。死亡的独立风险因素为未接种卡介苗(调整后的比值比 [AOR] 3.8,95%CI 1.8 至 8.1)、未使用地塞米松(AOR 2.5,95%CI 1.5 至 4.2)、男性(AOR 2.3,95%CI 1.5 至 3.6)、近期体重减轻史(AOR 2.2,95%CI 1.3 至 3.9)和 TBM Ⅲ期(AOR 2.0,95%CI 1.2 至 3.3)。
TBM 仍在阿富汗儿童中导致高发病率和死亡率。降低死亡率的策略应强调早期诊断和治疗、常规使用地塞米松和增加卡介苗接种。